文献速递乳腺癌

胚系BRCA突变乳腺癌患者妊娠后的结局

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations.
PubMed 文献 · J Clin Oncol · 2020-07-16

该国际多中心回顾性队列纳入1252例≤40岁、2000–2012年确诊的早期浸润性乳腺癌且携带致病性胚系BRCA突变的患者,评估乳腺癌后妊娠对结局的影响。10年妊娠率为19%,妊娠组与非妊娠组的无病生存和总生存均无显著差异,胎儿结局总体良好。

要点

  • BRCA突变乳腺癌患者妊娠后无病生存与总生存未变差。
  • 10年妊娠率19%,活产者中妊娠并发症11.6%、先天异常1.8%。
  • 结果可为有生育意愿的BRCA突变乳腺癌患者提供 reassurance。

核心结论

  • 胚系BRCA突变患者乳腺癌后妊娠安全,未明显恶化母亲预后,且胎儿结局良好。

研究设计与样本

  • 国际多中心、医院为基础的回顾性队列研究,纳入2000年1月至2012年12月确诊、年龄≤40岁的早期浸润性乳腺癌且携带致病性胚系BRCA突变患者1252例。

主要发现

  • 1252例中195例乳腺癌后至少妊娠1次,10年妊娠率19%(95%CI 17%–22%)。
  • 诱导流产16例(8.2%),自然流产20例(10.3%)。
  • 150例分娩(76.9%,共170名婴儿),妊娠并发症13例(11.6%),先天异常2例(1.8%)。
  • 中位随访8.3年,妊娠组与非妊娠组DFS无差异(校正HR 0.87;95%CI 0.61–1.23;P=.41)。
  • 两组OS无差异(校正HR 0.88;95%CI 0.50–1.56;P=.66)。

临床怎么用

  • 对有生育意愿的BRCA突变乳腺癌患者,可告知乳腺癌后妊娠不增加复发风险且胎儿结局良好。

局限性

  • 回顾性队列设计,妊娠组样本量有限(195例),结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Young women with germline BRCA mutations have unique reproductive challenges. Pregnancy after breast cancer does not increase the risk of recurrence; however, very limited data are available in patients with BRCA mutations. This study investigated the impact of pregnancy on breast cancer outcomes in patients with germline BRCA mutations. PATIENTS AND METHODS: This is an international, multicenter, hospital-based, retrospective cohort study. Eligible patients were diagnosed between January 2000 and December 2012 with invasive early breast cancer at age ≤ 40 years and harbored deleterious germline BRCA mutations. Primary end points were pregnancy rate, and disease-free survival (DFS) between patients with and without a pregnancy after breast cancer. Pregnancy outcomes and overall survival (OS) were secondary end points. Survival analyses were adjusted for guarantee-time bias controlling for known prognostic factors. RESULTS: Of 1,252 patients with germline BRCA mutations (BRCA1, 811 patients; BRCA2, 430 patients; BRCA1/2, 11 patients) included, 195 had at least 1 pregnancy after breast cancer (pregnancy rate at 10 years, 19%; 95% CI, 17% to 22%). Induced abortions and miscarriages occurred in 16 (8.2%) and 20 (10.3%) patients, respectively. Among the 150 patients who gave birth (76.9%; 170 babies), pregnancy complications and congenital anomalies occurred in 13 (11.6%) and 2 (1.8%) cases, respectively. Median follow-up from breast cancer diagnosis was 8.3 years. No differences in DFS (adjusted hazard ratio [HR], 0.87; 95% CI, 0.61 to 1.23; P = .41) or OS (adjusted HR, 0.88; 95% CI, 0.50 to 1.56; P = .66) were observed between the pregnancy and nonpregnancy cohorts. CONCLUSION: Pregnancy after breast cancer in patients with germline BRCA mutations is safe without apparent worsening of maternal prognosis and is associated with favorable fetal outcomes. These results provide reassurance to patients with BRCA-mutated breast cancer interested in future fertility.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Lambertini M, Ameye L, Hamy AS, et al. Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. J Clin Oncol. 2020. PMID: 32673153. doi:10.1200/JCO.19.02399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。